ATE312618T1 - Medizinische und kosmetische verwendung von hopfen und coenzym q10 - Google Patents
Medizinische und kosmetische verwendung von hopfen und coenzym q10Info
- Publication number
- ATE312618T1 ATE312618T1 AT02710559T AT02710559T ATE312618T1 AT E312618 T1 ATE312618 T1 AT E312618T1 AT 02710559 T AT02710559 T AT 02710559T AT 02710559 T AT02710559 T AT 02710559T AT E312618 T1 ATE312618 T1 AT E312618T1
- Authority
- AT
- Austria
- Prior art keywords
- hops
- coenzyme
- medical
- cosmetic use
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3486—Humulus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1017205A NL1017205C2 (nl) | 2001-01-26 | 2001-01-26 | Medicinale en cosmetische toepassing van hop en co-enzym Q10. |
| PCT/NL2002/000054 WO2002078727A1 (en) | 2001-01-26 | 2002-01-24 | Medicinal and cosmetic use of hop and co-enzyme q10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE312618T1 true ATE312618T1 (de) | 2005-12-15 |
Family
ID=19772801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02710559T ATE312618T1 (de) | 2001-01-26 | 2002-01-24 | Medizinische und kosmetische verwendung von hopfen und coenzym q10 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1359928B1 (de) |
| AT (1) | ATE312618T1 (de) |
| DE (1) | DE60207988D1 (de) |
| NL (1) | NL1017205C2 (de) |
| PL (1) | PL361929A1 (de) |
| WO (1) | WO2002078727A1 (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101395370B1 (ko) * | 2004-01-22 | 2014-05-14 | 유니버시티 오브 마이애미 | 국소용 코-엔자임 큐10 제형 및 그의 사용 방법 |
| WO2006017494A2 (en) * | 2004-08-02 | 2006-02-16 | Elizabeth Mazzio | Inhibition of anaerobic glucose metabolism |
| WO2007013556A1 (ja) * | 2005-07-28 | 2007-02-01 | Kaneka Corporation | 癌予防用組成物 |
| MX337408B (es) | 2007-03-22 | 2016-03-03 | Berg Llc | Formulaciones topicas que tienen biodisponibilidad aumentada. |
| MX2010011032A (es) | 2008-04-11 | 2011-03-01 | Cytotech Labs Llc Star | Metodos y uso de induccion de apoptosis en celulas cancerigenas. |
| CN102481271A (zh) | 2009-05-11 | 2012-05-30 | 博格生物系统有限责任公司 | 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法 |
| SG10202010355PA (en) | 2010-03-12 | 2020-11-27 | Berg Llc | Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| CA2832324C (en) | 2011-04-04 | 2022-03-15 | Berg Llc | Methods of treating central nervous system tumors |
| EP2720680B1 (de) | 2011-06-17 | 2020-02-12 | Berg LLC | Inhalbierbare pharmazeutische zusammensetzungen |
| NZ713868A (en) | 2013-04-08 | 2021-12-24 | Berg Llc | Treatment of cancer using coenzyme q10 combination therapies |
| KR102370843B1 (ko) | 2013-09-04 | 2022-03-04 | 버그 엘엘씨 | 코엔자임 q10의 연속주입에 의한 암치료 방법 |
| CN104623453A (zh) * | 2015-01-20 | 2015-05-20 | 刘保和 | 治疗妇女乳痰的药物制剂及制备 |
| WO2017087576A1 (en) | 2015-11-16 | 2017-05-26 | Berg Llc | Methods of treatment of temozolomide-resistant glioma using coenzyme q10 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS52145509A (en) * | 1976-05-27 | 1977-12-03 | Tokutarou Matsui | Antitumor agent |
| CN1031021A (zh) * | 1987-07-24 | 1989-02-15 | 天津市化妆品科学技术研究所 | 女性乳房健美化妆品 |
-
2001
- 2001-01-26 NL NL1017205A patent/NL1017205C2/nl not_active IP Right Cessation
-
2002
- 2002-01-24 AT AT02710559T patent/ATE312618T1/de not_active IP Right Cessation
- 2002-01-24 PL PL36192902A patent/PL361929A1/xx not_active Application Discontinuation
- 2002-01-24 EP EP02710559A patent/EP1359928B1/de not_active Expired - Lifetime
- 2002-01-24 WO PCT/NL2002/000054 patent/WO2002078727A1/en not_active Ceased
- 2002-01-24 DE DE60207988T patent/DE60207988D1/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002078727A1 (en) | 2002-10-10 |
| NL1017205C2 (nl) | 2002-07-29 |
| PL361929A1 (pl) | 2004-10-18 |
| EP1359928B1 (de) | 2005-12-14 |
| DE60207988D1 (de) | 2006-01-19 |
| EP1359928A1 (de) | 2003-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE312618T1 (de) | Medizinische und kosmetische verwendung von hopfen und coenzym q10 | |
| MY136926A (en) | Glucokinase activators | |
| AU2003282233A1 (en) | Quinoline derivatives as glucokinase ligands | |
| GB0226930D0 (en) | Chemical compounds | |
| PE20020593A1 (es) | Activadores de glucocinasa del tipo isoindolin-2-ona | |
| CY1107509T1 (el) | Αμινοθειαζολες ως αναστολεις κυκλινη - εξαρτωμενων κινασεων | |
| CY1107862T1 (el) | Φαρμακευτικες συνθεσεις που περιλαμβανουν παραγωγα οιστερολης για χρηση στη θεραπεια του καρκινου | |
| HUP0202897A2 (hu) | Diaminotiazolok és a vegyületek protein kinázok gátlására való alkalmazása és ezeket tartalmazó gyógyszerkészítmények | |
| PL354030A1 (en) | Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis | |
| MXPA02010088A (es) | Derivados de ecteinascidina antitumorales. | |
| IL135438A (en) | Pharmaceutical compositions containing styrl sulfones and some such novel styryl sulfone compounds with anticancer activity | |
| CY1110284T1 (el) | Παραγωγα της 2-αμινο-4-πυριδυλομεθυλο-θειαζολινης και η χρηση τους ως αναστολεις της επαγωγιμης συνθασης νο | |
| DE69713273D1 (de) | Verwendung von 3,4-Diphenylchromanen zur Herstellung eines Arzneimittels zur Behandlung bzw. Vorbeugung des Prostatakarzinoms | |
| IT1315267B1 (it) | Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale | |
| NZ500992A (en) | Arylsubstituted piperazines useful in the treatment of benign prostatic hyperplasia | |
| PE20000244A1 (es) | Derivados de 5`-desoxicitidina | |
| YU46302A (sh) | Supstituisani piroli | |
| ATE273978T1 (de) | 7-aminopyrido(2,3-d)-pyrimidine derivate zur behandlung von bronchialasthma | |
| MXPA02002007A (es) | Compuestos de bencimidazol sustituidos con alcoxi, preparaciones farmaceuticas que contienen los mismos, metodos para usarlos. | |
| EA200600092A1 (ru) | Новые цитотоксические депсипептиды | |
| AU2003236701A1 (en) | Guanidino phenylalanin compounds used as urokinase inhibitors | |
| TR200001926T2 (tr) | Vasküler başağrılarına karşı lokal anesteziklerin yeni kullanımı | |
| DE60102142D1 (de) | Kosmetische verwendung von hopfen und ornithin | |
| ATE218138T1 (de) | N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung | |
| AU4302996A (en) | Uracil derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |